Peak Financial Management’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$405K Buy
350
+30
+9% +$35.4K 0.09% 68
2026
Q2
$384K Buy
+320
New +$327K 0.09% 68
2026
Q1
– Sell
-291
Closed -$313K – 102
2025
Q4
$313K Sell
291
-25
-8% -$23.9K 0.08% 74
2025
Q3
$241K Buy
316
+30
+10% +$22.3K 0.06% 84
2025
Q2
$223K Sell
286
-34
-11% -$26.4K 0.06% 89
2025
Q1
$264K Sell
320
-45
-12% -$37.4K 0.08% 76
2024
Q4
$282K Buy
365
+136
+59% +$113K 0.08% 77
2024
Q3
$203K Sell
229
-189
-45% -$170K 0.06% 98
2024
Q2
$378K Sell
418
-235
-36% -$188K 0.12% 68
2024
Q1
$508K Buy
653
+263
+67% +$187K 0.16% 54
2023
Q4
$227K Buy
+390
New +$228K 0.08% 79
2023
Q3
– Sell
-584
Closed -$274K – 75
2023
Q2
$274K Buy
+584
New +$245K 0.1% 71

Other funds holding LLY

Peak Financial Management's LLY Position: Q3 2026 in Review

Peak Financial Management increased its Eli Lilly (LLY) stake by 9.4% in Q3 2026, buying an estimated $35.4K and bringing the position to 350 shares worth $405K. The position accounts for 0.09% of the portfolio, ranked #68.

Peak Financial Management first reported a position in LLY in Q2 2023 and has held it in 12 quarters since. The position peaked at $508K in Q1 2024. 3,244 funds tracked by Wall St. Rank hold LLY as of Q3 2026.

  • Peak Financial Management held 350 shares of Eli Lilly worth $405K as of Q3 2026.
  • Peak Financial Management bought 30 Eli Lilly shares in Q3 2026, an estimated $35.4K.
  • Eli Lilly made up 0.09% of Peak Financial Management's portfolio in Q3 2026, its #68 holding.
  • Peak Financial Management first reported a position in Eli Lilly in Q2 2023 and has held it in 12 quarters since.
  • Peak Financial Management's Eli Lilly position peaked at $508K in Q1 2024.
  • 3,244 funds tracked by Wall St. Rank held Eli Lilly as of Q3 2026.

Based on Peak Financial Management's 13F filing for Q3 2026, filed 16 Oct 2026.